MedAvant to Extend 10-K Filing Date and Files Extension Request

ATLANTA, March 31, 2008 (PRIME NEWSWIRE) -- MedAvant Healthcare Solutions
(MedAvant) (Nasdaq:PILL), a leader in healthcare technology and transaction
services, today announced that it requires additional time to finalize its
fourth quarter financial statements and Annual Report on Form 10-K for the year
ended December 31, 2007. Accordingly, it has filed a notification with the
Securities and Exchange Commission on Form 12b-25 for the permitted 15 day
extension, and the Company anticipates that it will file its Form 10-K on or
before April 15, 2008.

"We need to file this extension due to the changes that occurred in the first
quarter of 2008," said Peter Fleming, MedAvant's Interim Chief Executive
Officer. "We've not only had a change in our auditing firm, but we've also
closed the sale of our PPO and have had changes in our senior management team.
The extension allows us needed time to finalize our year-end 2007 results and
disclosures."

Fleming continued, "We also plan to hold an investor conference call upon the
completion of our year end reporting process and Form 10-K filing. We will
provide the customary advance notice of that call."

About MedAvant Healthcare Solutions

MedAvant is focused on facilitating the exchange of healthcare information so
that payers, providers, and patients benefit equally from the sharing of
reliable and actionable health data. To enables these services, MedAvant
operates Phoenix(sm), a highly scalable platform that supports real-time
connections between healthcare clients.

For more information, visit http://www.medavanthealth.com. MedAvant is a trade
name of ProxyMed, Inc.

The MedAvant Healthcare Solutions logo is available at
http://www.primenewswire.com/newsroom/prs/?pkgid=3540

Forward Looking Statement

Statements in this release that are "forward-looking statements" are based on
current expectations and assumptions that are subject to risks and
uncertainties. In some cases, forward-looking statements can be identified by
terminology such as "may," "should," "potential," "continue," "expects,"
"anticipates," "intends," "plans," "believes," "estimates," and similar
expressions. Actual results could differ materially from projected results
because of factors such as:

* The soundness of our business strategies relative to the perceived
market opportunities;
* Our ability to successfully develop, market, sell, cross-sell,
install and upgrade our clinical and financial transaction services
and applications to current and new physicians, payers and medical
laboratories;
* Our ability to compete effectively on price and support services;
* Our ability and that of our business associates to perform
satisfactorily under the terms of our contractual obligations, and
to comply with various government rules regarding healthcare and
patient privacy;
* Entry into markets with vigorous competition, market acceptance of
existing products and services, changes in licensing programs,
product price discounts, delays in product development and related
product release schedules, any of which may cause our revenues and
income to fall short of anticipated levels;
* The availability of competitive products or services;
* The continued ability to protect our intellectual property rights;
* Implementation of operating cost structures that align with revenue
growth;
* Uninsured losses;
* Adverse results in legal disputes;
* Unanticipated tax liabilities; and
* The effects of a natural disaster or other catastrophic event
beyond our control that results in the destruction or disruption of
any of our critical business or information technology systems.
Any of these factors could cause the actual results to differ materially from
the guidance given at this time. For further cautions about the risks of
investing in MedAvant, we refer you to the documents MedAvant files from time to
time with the Securities and Exchange Commission, including, without limitation,
its most recently filed Annual Report on Form 10-K. MedAvant does not assume,
and expressly disclaims, any obligation to update information contained in this
document. Although this release may remain available on our website or
elsewhere, its continued availability does not indicate that we are reaffirming
or confirming any of the information contained herein.

-0-
CONTACT: MedAvant Healthcare Solutions
Media Contact:
Teresa Stubbs
812-206-4332
tstubbs@medavanthealth.com

Institutional Marketing Services, Inc.
Investor Relations Contact:
John G. Nesbett
jnesbett@institutionalms.com
Jen Belodeau
203-972-9200